ARS Pharmaceuticals CEO Laura Shawver's 2022 pay jumps 608% to $5.8M
ARS Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: May 1, 2023
ARS Pharmaceuticals reported fiscal year 2022 executive compensation information on May 1, 2023.
In 2022, seven executives at ARS Pharmaceuticals received on average a compensation package of $2.1M, a 200% increase compared to previous year.
Average pay of disclosed executives at ARS Pharmaceuticals
Laura Shawver, Chief Executive Officer, received $5.8M in total, which increased by 608% compared to 2021.
Valerie Odegard, Chief Scientific Officer, received a compensation package of $2.9M, which increased by 365% compared to previous year. 54% of the compensation package, or $1.6M, was in other compensation.
Jonathan Piazza, Chief Financial Officer, earned $2.4M in 2022, a 286% increase compared to previous year.
Jeffrey Pepe, Chief Executive Officer, received $2.3M in 2022.
Richard Lowenthal, M.S., MSEL, Chief Executive Officer, earned $476K in 2022.
Sarina Tanimoto, Chief Medical Officer, received $338K in 2022.
Eric Karas, Chief Commercial Officer, earned $223K in 2022.
Related executives
Richard MSEL
ARS Pharmaceuticals
Chief Executive Officer
Sarina Tanimoto
ARS Pharmaceuticals
Chief Medical Officer
Eric Karas
ARS Pharmaceuticals
Chief Commercial Officer
Laura Shawver
ARS Pharmaceuticals
Chief Executive Officer
Jeffrey Pepe
ARS Pharmaceuticals
Chief Executive Officer
Valerie Odegard
ARS Pharmaceuticals
Chief Scientific Officer
Jonathan Piazza
ARS Pharmaceuticals
Chief Financial Officer
You may also like
Source: SEC filing on May 1, 2023.